BRIEF published on 11/19/2026 at 07:35, 3 days 9 hours ago Evotec and Bristol Myers Squibb Expand Protein Degradation Partnership FDA Approval Clinical Trials Oncology Evotec Protein Degradation
PRESS RELEASE published on 11/19/2026 at 07:30, 3 days 9 hours ago Evotec and Bristol Myers Squibb Advance Strategic Protein Degradation Partnership with Second IND Acceptance
BRIEF published on 11/16/2026 at 07:35, 6 days 9 hours ago Evotec Receives $2.9 Million Grant for Drug Safety Testing Enhancement Evotec Drug Safety Grant Funding Gates Foundation Stem Cell Technology
PRESS RELEASE published on 11/16/2026 at 07:30, 6 days 9 hours ago Evotec Secures $2.9 Million Grant to Advance Early Drug Safety Testing Using Human Stem Cell Technology
BRIEF published on 11/05/2026 at 07:35, 17 days 9 hours ago Evotec's Strong Q3 2026 Results: A Path to Growth by 2030 Strategic Partnerships Commercial Expansion Evotec Results 2026 Financial Highlights 2030 Growth Goals
PRESS RELEASE published on 11/05/2026 at 07:30, 17 days 9 hours ago Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 Goals
BRIEF published on 10/29/2026 at 07:35, 24 days 9 hours ago Evotec SE to Announce Q3 2026 Financial Results Financial Results Conference Call Drug Discovery Evotec SE Webcast Announcement
PRESS RELEASE published on 10/29/2026 at 07:30, 24 days 9 hours ago Evotec SE to Announce Results for the First Nine Months 2026 on November 5, 2026
BRIEF published on 10/15/2026 at 07:35, 1 month 7 days ago Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer Biotechnology Drug Discovery Evotec Joanna Holbrook Scientific Strategy
PRESS RELEASE published on 10/15/2026 at 07:30, 1 month 7 days ago Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board Evotec appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board. Dr. Holbrook brings 25+ years experience in pharma, biotech, and academia Chief Scientific Officer Management Board Evotec Pharma Dr. Joanna Holbrook
Published on 11/20/2026 at 15:00, 2 days 1 hour ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 2 days 1 hour ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 2 days 2 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 2 days 3 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 2 days 3 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 1 day 16 hours ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 21:36, 1 day 19 hours ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 19:26, 1 day 21 hours ago EQS-Adhoc: TAKKT AG: TAKKT revises its 2026 full-year forecast following the cyberattack
Published on 11/20/2026 at 19:03, 1 day 21 hours ago EQS-Adhoc: Allgeier SE confirms rumors regarding sale process for the Evora Group
Published on 11/20/2026 at 18:34, 1 day 22 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 1 day 23 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 2 days 21 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 08:30, 3 days 8 hours ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing